Document Detail


Complete myocardial revascularization: between myth and reality.
MedLine Citation:
PMID:  15824076     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myocardial revascularization in patients with multi-vessel coronary artery disease may be accomplished, by percutaneous interventions or surgery, either on all diseased lesions or directed to selectively targeted coronary segments. The extent of planned revascularization is often a major determinant of treatment strategy. Revascularization of all diseased coronary segments-complete myocardial revascularization-has a potential long-term benefit, but is more complex and may increase in-hospital untoward events. Revascularization may otherwise be incomplete, either because of the operator's inability to treat all diseased coronary segments or by choice of deciding to selectively revascularize only large areas of myocardium at risk. Although incomplete revascularization may negatively affect long-term outcomes, it may be, when wisely chosen, the preferred treatment strategy in selected patient categories because of its lower immediate risks. The patient's clinical status, ventricular function, and the presence of co-morbidities may orient clinical decisions in favour of incomplete revascularization.
Authors:
Marco Zimarino; Antonio Maria Calafiore; Raffaele De Caterina
Related Documents :
16908896 - Revascularization in patients with heart failure.
24241246 - The role of monocyte phenotype switching in peri-procedural myocardial injury and its i...
12902086 - The effect of left internal mammary artery utilization on short-term outcomes after cor...
9564946 - Transmyocardial laser revascularization in allograft coronary artery disease.
6476996 - Coronary flow reserve measured during cardiac catheterization.
8912266 - Cardiac baroreflex properties in myocardial infarcted rats.
Publication Detail:
Type:  Journal Article; Review     Date:  2005-04-11
Journal Detail:
Title:  European heart journal     Volume:  26     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-29     Completed Date:  2006-02-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1824-30     Citation Subset:  IM    
Affiliation:
Institute of Cardiology and Centre of Excellence on Aging, 'G. d'Annunzio' University, Ospedale S. Camillo de Lellis, Via Forlanini, 50, 66100 Chieti, Italy. m.zimarino@unich.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary / methods
Clinical Trials as Topic
Coronary Disease / therapy*
Disease-Free Survival
Humans
Kidney Diseases / complications
Myocardial Revascularization / methods*
Postoperative Complications / etiology
Risk Factors
Stents
Treatment Outcome
Ventricular Dysfunction, Left / etiology
Comments/Corrections
Comment In:
Eur Heart J. 2005 Sep;26(17):1809-10; author reply 1810-1   [PMID:  15987705 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disea...
Next Document:  Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?